During the past decade, Karla Adriana Espinosa Bautista conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Karla Adriana Espinosa Bautista" are "Moderate to Severe Ulcerative Colitis" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Karla Adriana Espinosa Bautista" in a lesser frequency.

Most popular intervention types in "Karla Adriana Espinosa Bautista" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "0 mg Induction ONLY" (1 trials), "150 mg Induction/Chronic" (1 trials), "450 mg Induction/Chronic" (1 trials), "50 mg Induction/Chronic" (1 trials) and "Cenerimod 0.5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Karla Adriana Espinosa Bautista" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Karla Adriana Espinosa Bautista". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Karla Adriana Espinosa Bautista, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Karla Adriana Espinosa Bautista, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".